Zacks Investment ResearchFri, 08 May 2026 17:01:06 GMTOcugen (OCGN) Upgraded to Buy: Here's WhyOCGN0.00%
Zacks Investment ResearchWed, 06 May 2026 17:05:34 GMTOCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress OutlookOCGN0.00%
Seeking AlphaTue, 05 May 2026 18:51:27 GMTOcugen, Inc. (OCGN) Q1 2026 Earnings Call TranscriptOCGN0.00%
Zacks Investment ResearchTue, 05 May 2026 15:00:39 GMTOcugen (OCGN) Reports Q1 Loss, Beats Revenue EstimatesOCGN0.00%
Zacks Investment ResearchWed, 22 Apr 2026 17:36:17 GMTOCGN's Gene-Agnostic Strategy Could Reset Retinal TherapyOCGN0.00%
Zacks Investment ResearchWed, 22 Apr 2026 17:36:11 GMTOcugen Stock Outlook: Valuation, Cash Runway and Dilution RiskOCGN0.00%
Zacks Investment ResearchWed, 22 Apr 2026 17:36:07 GMTOCGN Gene Therapy Pipeline: Key 2026-27 Catalysts AheadOCGN0.00%
Zacks Investment ResearchFri, 03 Apr 2026 16:31:15 GMTOcugen (OCGN) Up 2.9% Since Last Earnings Report: Can It Continue?OCGN0.00%
Zacks Investment ResearchThu, 02 Apr 2026 15:15:33 GMTOCGN Completes Early Enrollment in Pivotal Stargardt Disease StudyOCGN0.00%
Zacks Investment ResearchWed, 25 Mar 2026 17:15:23 GMTOcugen Falls as Gene Therapy for Eye Disease Lags in Phase II StudyOCGN0.00%
Seeking AlphaTue, 24 Mar 2026 21:54:50 GMTOcugen, Inc. (OCGN) Discusses Top Line Results From Phase II ArMaDa Trial of OCU410 in Geographic Atrophy TranscriptOCGN0.00%
BenzingaTue, 24 Mar 2026 14:40:11 GMTOcugen Eye Disease Gene Therapy Data Trails Earlier Results, Stocks FallsOCGN0.00%
Zacks Investment ResearchFri, 20 Mar 2026 13:01:16 GMTOcugen Stock Outlook: Balancing Cash Burn and Late-Stage DataOCGN0.00%
Zacks Investment ResearchFri, 20 Mar 2026 13:01:14 GMTOCGN Gene Therapy Pipeline: 2026-2027 Catalysts To WatchOCGN0.00%
Zacks Investment ResearchFri, 20 Mar 2026 13:01:13 GMTOCGN Gene-Agnostic Eye Therapy Could Shift Retinal Drug DevelopmentOCGN0.00%
24/7 Wall StreetWed, 11 Mar 2026 14:23:29 GMTOppenheimer Starts Ocugen (OCGN) at Outperform on Gene Therapy PipelineOCGN0.00%
Seeking AlphaWed, 04 Mar 2026 18:32:13 GMTOcugen, Inc. (OCGN) Q4 2025 Earnings Call TranscriptOCGN0.00%
Zacks Investment ResearchWed, 04 Mar 2026 15:26:09 GMTOcugen (OCGN) Reports Q4 Loss, Lags Revenue EstimatesOCGN0.00%